Abbott Laboratories (ABT)

85.77
0.99 1.20
NYSE : Health Technology
Prev Close 84.78
Open 85.79
Day Low/High 85.33 / 86.08
52 Wk Low/High 64.03 / 88.76
Volume 979.48K
Avg Volume 4.98M
Exchange NYSE
Shares Outstanding 1.77B
Market Cap 148.36B
EPS 1.30
P/E Ratio 51.81
Div & Yield 1.28 (1.48%)
Cramer: Top 10 Bull Markets Right Now

Cramer: Top 10 Bull Markets Right Now

Bull market number one, perhaps of all time: the financials.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

These stocks are indicating a change in direction.

A Play on Intel's Breakdown

A Play on Intel's Breakdown

With trend favoring the bears, I'm favoring a bearish call spread.

Abbott Labs: Diagnosing Growth in 2017

Abbott Labs: Diagnosing Growth in 2017

ABT could be on course for 10% earnings growth this year, but will investors reward the company with a higher share price?

Dump These 5 'Toxic Stocks' Before the New Year

Dump These 5 'Toxic Stocks' Before the New Year

Start 2017 on the right foot by selling your holdings in these five stocks.

Abbott Laboratories Can Merge With St. Jude Medical: FTC

Abbott Laboratories Can Merge With St. Jude Medical: FTC

The Federal Trade Commission says Abbott Laboratories can proceed with its proposed $25 billion acquisition of St. Jude Medical.

Top 5 Dividend Stocks to Buy Now for 2017

Top 5 Dividend Stocks to Buy Now for 2017

Here is a look at some stocks that are poised for excellent dividend returns in 2017.

Abbott Labs Is Likely to See Further Weakness

Abbott Labs Is Likely to See Further Weakness

Look for ABT's declining trend to continue a while longer.

The Good, the Bad and the Ugly

"You see, in this world there's two kinds of people, my friend: Those with loaded guns and those who dig. You dig." -- Blondie in "The Good, the Bad and the Ugly." I did very little today.   Markets were higher from the get-go and seemed "stuck" nea...

Abbott Labs Shares Climb on Better-Than-Expected Earnnigs

Abbott Labs Shares Climb on Better-Than-Expected Earnnigs

Shares of the medical-device giant were climbing after unveiling strong earnings.

Jim Cramer: Drug Stocks Feeling Political Pressure

Jim Cramer: Drug Stocks Feeling Political Pressure

Political pressure is weighing on drug and medical device stocks including Abbott Labs and St. Jude, says Jim Cramer.

Jim Cramer: St. Jude Battery Woes Big But Not a Dealbreaker

Jim Cramer: St. Jude Battery Woes Big But Not a Dealbreaker

St. Jude's warning about battery risks in its implanted heart devices are big but will likely not disrupt its deal with Abbott Labs.

Closing Bell: LionsGate's 'Blair Witch' Set to Own Box Office; U.S. Stocks Fall

Closing Bell: LionsGate's 'Blair Witch' Set to Own Box Office; U.S. Stocks Fall

U.S. stocks ended Friday's session lower as a crude oil selloff pressures the energy sector and nerves over next week's Federal Reserve meeting peak.

4 Market Segments to Avoid

4 Market Segments to Avoid

These sectors are full of high-priced, low-growth stocks.

Cramer: The Answer to This Market: Part 1

Cramer: The Answer to This Market: Part 1

The leadership is quite stark.

Charts Emit a Yellow 'Caution' Signal

Charts Emit a Yellow 'Caution' Signal

The signs that have warned of a possible market reversal only have become more extreme.

Trending Tickers: SWN, ABT, AAL, UAL, EW

Oil began to rebound Wednesday from steep declines earlier this week.

Traders, Here's Your 'Short' Notice

Traders, Here's Your 'Short' Notice

They should wait until the rally appears to be running out of steam in order to go in on the short side.

Cramer: Worst May Be Over for Embattled Pharma

The M&A activity is an incredible and a welcome sign.

Jim Cramer: I’m a Huge Backer of Abbott Labs CEO Miles White

Jim Cramer: I’m a Huge Backer of Abbott Labs CEO Miles White

Jim Cramer is bullish on Abbott Laboratories' acquisition of St. Jude Medical.

U.S. Stocks Slip on Sluggish GDP; Ford Posts Record Profit

U.S. Stocks Slip on Sluggish GDP; Ford Posts Record Profit

U.S. stocks dropped on Thursday, as first quarter gross domestic product came in weaker than expected.

Even the Fed Can't Make Stocks Budge

Even the Fed Can't Make Stocks Budge

Movement has become difficult after weeks of advances, which suggests a downturn may be near.

Jim Cramer Says You Want to Own This Health Care Stock

Jim Cramer Says You Want to Own This Health Care Stock

Jim Cramer believes Abbott Labs' CEO Miles White is doing a terrific job of making the company better.

Stericycle Is a Good Shorting Candidate

Stericycle Is a Good Shorting Candidate

This stock is well into overbought territory.

Small-Cap 'Mutiny' Spells Trouble

Small-Cap 'Mutiny' Spells Trouble

The Russell 2000's failure to follow the S&P and Dow's lead is only one reason for concern.

Alere's Stock Spikes Following News of Its Impending Buy by Abbott

Alere's Stock Spikes Following News of Its Impending Buy by Abbott

Shares of Alere soared on Monday on word that Abbott Labs would acquire the company in a deal valued at $7.9 billion.

Abbott downgraded at William Blair

Health Care Stocks Are Getting 'Uber-ed' by Ashton Kutcher

Two significant, but subtle forces may threaten the group in the next 12 months.

Cramer: Dow Chemical-DuPont Merger Will Instantly Create Value

The merged company can become multiple companies.